Latest Insights on ORA

November 17, 2023 Banyan Edge, Diversified Investments, Trending
From Chealsea Handler to Elon Musk, Novo Nordisk's Ozempic has been hailed a "miracle drug." Is it worth investing in?
November 8, 2023 Banyan Edge, Investment Opportunities, Stocks
The Charles Schwab Corporation (NYSE: SCHW) has been heralded the "worst-performing stock" in the S&P 500. Here's why you should be bullish.
November 7, 2023 Banyan Edge, Cryptocurrency, Investment Opportunities
Solana (SOL) has an upgrade coming. "Firedancer" could make this crypto 10X faster than Ethereum, making it a rival for Top Crypto.
November 2, 2023 Banyan Edge, News, U.S. Economy
The power to raise or lower interest rates might actually be the Federal Reserve’s least effective tool against inflation.
October 22, 2023 Banyan Edge, Investing, Stocks, Trading Strategies
This one's all about “low-risk, high-reward” investments. Including a company that's legally required to pay a massive dividend.